Job-ID: 61716
Location: Wien, AUT; Lingolsheim, FRA; Springe, DEU; Stockholm, SWE
Job Level: Professionals
Category: Technical
Employment Type: Permanent position
Become part of a vital chain and contribute to our common goal of making people's lives better. Octapharma is one of the largest human protein manufacturers in the world, developing and producing medicines sourced from human plasma and human cell lines. We are a privately-owned company, where the warmth of family meets the scale of a global organisation.
As a Group Utility Engineer, you will support the development of utility infrastructure within our international engineering projects, helping to build and optimize pharmaceutical production facilities from concept to implementation. You will ensure reliable, compliant and high-performance utility solutions aligned with Octapharma's global engineering framework.
The position will be filled in Vienna (Austria), Springe (Germany), Stockholm (Sweden) or Lingolsheim (France).
Join us in shaping our vision of providing new health solutions advancing human life.
You will thrive in this role if you are driven to design resilient and future-focused utility systems, enjoy collaborating across international teams, and bring strong technical expertise together with a proactive, solution-oriented mindset.
We live diversity and stand for equal opportunities as an employer! We therefore look forward to receiving your application - regardless of age, gender, origin, sexual orientation, and religion.
Do you have any questions? Then get in touch with your contact person.
Larissa Amling
Octapharma Pharmazeutika Produktionsges.m.b.H.
Oberlaaer Straße 235, 1100 Wien
T: +43 664 789 52 728
Visit our website Octapharma Career and follow us daily on LinkedIn.
Octapharma is one of the largest human protein manufacturers in the world, developing and producing human proteins from human plasma and human cell lines. We employ more than 11,000 people worldwide to support the treatment of patients in 120 countries with products across three therapeutic areas: Immunotherapy, Haematology and Critical Care. With seven R&D sites and five state-of-the-art manufacturing facilities in Austria, France, Germany, and Sweden, Octapharma also operates over 195 plasma donation centres across Europe and the US. With four decades of experience, we are committed to advancing patient care worldwide.